National Institute on Drug Abuse; Notice of Meeting, 52752 [2012-21332]
Download as PDF
<![CDATA[
52752
Federal Register / Vol. 77, No. 169 / Thursday, August 30, 2012 / Notices
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Medical Imaging
Study Section.
Date: October 3–4, 2012.
Time: 7 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Xiang-Ning Li, M.D.,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112,
MSC 7854, Bethesda, MD 20892, 301–435–
1744, lixiang@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 24, 2012.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–21331 Filed 8–29–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Institute on Drug Abuse;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Drug
Abuse.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: September 5–6, 2012.
Closed: September 5, 2012, 2 p.m. to 5 p.m.
VerDate Mar<15>2010
18:27 Aug 29, 2012
Jkt 226001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Rooms C & D,
Rockville, MD 20852.
Open: September 6, 2012, 8:30 a.m. to 1
p.m.
Agenda: This portion of the meeting will
be open to the public for announcements and
reports of administrative, legislative and
program developments in the drug abuse
field.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Rooms C & D,
Rockville, MD 20852.
Contact Person for More Information:
Teresa Levitin, Ph.D., Director, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4243, MSC
9550, 6001 Executive Boulevard, Bethesda,
MD 20892–89550, (301) 443–2755,
tlevitin.nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page:
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: August 24, 2012.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–21332 Filed 8–29–12; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Refugee Resettlement
[C.F.D.A. Number: 93.566]
Notice of FY 2012 Refugee Social
Services Formula Awards to States
and Wilson/Fish Alternative Project
Grantees
Office of Refugee Resettlement,
ACF, HHS.
AGENCY:
ACTION:
Notice of awards.
CFDA Number: 93.566.
SUMMARY: The Office of Refugee
Resettlement, Administration for
Children and Families (ACF),
announces the allocation of Refugee
Social Services formula awards to States
and Wilson/Fish Alternative Project
grantees. The purpose of the Social
Services program is to provide
employment, English language,
orientation, and other resettlement
services to refugees, Amerasians,
asylees, Cuban and Haitian entrants,
victims of trafficking, and Iraqis and
Afghans with Special Immigrant Visas.
The awards are determined by the
number of the eligible populations
residing in the State during the two-year
period from October 1, 2009, to
September 30, 2011. States with
allocations under $100,000 through this
calculation instead receive floor
allocations ranging from $75,000 to
$100,000 depending on the number of
the eligible population in each State.
The purpose of the floor allocations is
to ensure that all participating States
receive an award sufficient to maintain
a program of resettlement services.
The FY 2012 formula allocations for
Social Services are available on ORR’s
Web site at: https://www.acf.hhs.gov/
programs/orr/policy/fy2012_formula
_allocations_refugee_socialservices.htm.
The awards are effective
immediately. Funds must be obligated
by September 30, 2013, and funds must
be expended by September 30, 2014.
DATES:
FOR FURTHER INFORMATION CONTACT:
Henley Portner, Office of the Director,
Office of Refugee Resettlement, (202)
401–5363, Henley.Portner@acf.hhs.gov.
Statutory Authority: Sections 412(c)(1)(B)
of the Immigration and Nationality Act (INA)
(8 U.S.C. 1522(c)(1)(B)).
Eskinder Negash,
Director, Office of Refugee Resettlement.
[FR Doc. 2012–21401 Filed 8–29–12; 8:45 am]
BILLING CODE 4184–46–P
Frm 00077
Fmt 4703
Sfmt 4703
E:\FR\FM\30AUN1.SGM
30AUN1
]]>Agencies
[Federal Register Volume 77, Number 169 (Thursday, August 30, 2012)]
[Notices]
[Page 52752]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-21332]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council on Drug Abuse.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Drug Abuse.
Date: September 5-6, 2012.
Closed: September 5, 2012, 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Conference Rooms C & D, Rockville, MD 20852.
Open: September 6, 2012, 8:30 a.m. to 1 p.m.
Agenda: This portion of the meeting will be open to the public
for announcements and reports of administrative, legislative and
program developments in the drug abuse field.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Conference Rooms C & D, Rockville, MD 20852.
Contact Person for More Information: Teresa Levitin, Ph.D.,
Director, Office of Extramural Affairs, National Institute on Drug
Abuse, NIH, DHHS, Room 4243, MSC 9550, 6001 Executive Boulevard,
Bethesda, MD 20892-89550, (301) 443-2755, tlevitin.nida.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: August 24, 2012.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-21332 Filed 8-29-12; 8:45 am]
BILLING CODE 4140-01-P
